Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2017/05/19Adocia to hold its annual shareholders’ meeting on June 27, 2017 in Paris
2017/04/18Adocia announces the release of its Reference Document, containing the Annual Financial Report and the Management Report, for the year 2016
30 mai 2017 15th Healthcare Midcaps Forum – Gilbert Dupont Bank brokerage firm – Paris, France - Some thirty Midcaps, representative of the health sector, will meet with a large population of Institutional and Private Managers of the strategy and prospects of their company